Chemed Corporation · CHE
$539M
$541M
$531M
$531M
$526M
$547M
$560M
$554M
$565M
$586M
$589M
$596M
$606M
$640M
$647M
$619M
$625M
$639M
$658M
—
20-quarter listed-company comparison
Medical Care Facilities Stocks
Medical Care Facilities: Fresenius Medical Care AG owns the largest revenue base; Astrana Health, Inc. has the fastest current growth.
01 · the industry itself · before any single company
How has Medical Care Facilities moved against S&P 500?
The line below covers up to 5.2 years and opens on the 5Y view; the buttons cut it shorter. Over the most recent two of them this industry is 8% ahead of S&P 500. Earnings across its companies grew 7% on average over the last four reported quarters — close to flat. It has been ahead of S&P 500 on a rolling three-month view for 31 weeks running.
LEADER · ahead 31w✓Moving with the index21 of 39 companies ahead of S&P 500 by 5% or more over three months3 are 20% or more behind over a year while earnings grew 20% or more
RS ↑31w · 34/39 >200d (+1) · 21/39 lead (−3) · EPS 26/38↑
Medical Care Facilities, equal-weighted, based at 200
S&P 500, same base, same start
trailing 12-month earnings per share rising
falling
Medical Care Facilities, equal-weighted, based at 200
S&P 500, same base, same start
trailing 12-month earnings per share rising
falling
Medical Care Facilities, equal-weighted, based at 200
S&P 500, same base, same start
trailing 12-month earnings per share rising
falling
Both lines start at 200 in the same week, so the distance between them is the whole story: the industry line is an equal-weighted index of its 39 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the industry taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.
02 · sector relative strength, before individual stocks
Is Medical Care Facilities outperforming S&P 500?
Medical Care Facilities has outperformed S&P 500 by 45.7% over the last 52 weeks. Over 13 weeks the gap is a lead of 11.6%. 21 of 30 covered companies currently beat the S&P 500 on Mansfield relative strength, so leadership inside the sector is selective. agilon health, inc. is the strongest against the sector itself at +87%.
+11.6%Sector vs S&P 500 · 13 weeks
+45.7%Sector vs S&P 500 · 52 weeks
21/30Stocks leading S&P 500
10/30Stocks leading sector
Sector metric: — as of latest available · unclassified · direction unavailable.
The central tension: the companies with the most scale are not necessarily the companies creating the most change.
Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.
Bottom line
Medical Care Facilities has outperformed S&P 500 by 45.7% over 52 weeks and 11.6% over 13 weeks. 21 of 30 covered companies beat the S&P 500 on Mansfield relative strength, while 10 of 30 beat the sector itself. Fresenius Medical Care AG leads with revenue of $19,359 million, based on 19 of 30 comparable companies through Mar 2026.
Companies
30
complete canonical membership
Combined market value
$227.5B
HCA Healthcare, Inc.
Revenue growing
15/19
positive TTM year-on-year growth
Beating S&P 500
21/30
positive Mansfield relative strength
Comparing 5 of 30
03 · research priority, made explicit
4-Factor Sector Score
An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.
Growth & earnings · 35%Capital efficiency · 25%Valuation · 20%Relative strength · 20%
AMN Healthcare Services, Inc. has the strongest current balance of earnings trajectory, business quality, valuation and price confirmation, with 57.6% evidence confidence.
Select Medical Holdings Corporation looks inexpensive relative to peers or its own history, but its earnings trajectory has not yet earned the valuation signal.
DaVita Inc. has stronger price confirmation than earnings confirmation; that is a research prompt, not permission to chase.
How this score is built, and what the marks mean
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1AMN Healthcare Services, Inc.AMN | 64.5/100Thin evidence · provisional58% evidence | LEADER | 26.0/35 Revenue 19.8% · PAT — · OPM change 6.7 pp 62% evidence | 13.2/25 ROCE 6.9% · OPM 8.5% 76% evidence | 9.2/20 P/E 30.7× · PEG — 15% evidence | 16.1/20 RS sector 15.6% · RS bench 36.1% · 1Y 92.9%12 of 12 weeks ahead 70% evidence |
| Exact sum: 26 + 13.2 + 9.2 + 16.1 = 64.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2Tenet Healthcare CorporationTHC | 64.4/100Thin evidence · provisional58% evidence | TURNING | 23.7/35 Revenue — · PAT — · OPM change 6.2 pp 45% evidence | 16.5/25 ROCE 5.8% · OPM 23.2% 76% evidence | 11.1/20 P/E 7.2× · PEG — 15% evidence | 13.1/20 RS sector -5.5% · RS bench 13.7% · 1Y 53%3 of 12 weeks ahead 100% evidence |
| Exact sum: 23.7 + 16.5 + 11.1 + 13.1 = 64.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Concentra Group Holdings Parent, Inc.CON | 60.1/100Mixed-positive evidence71% evidence | BREAKING OUT | 19.8/35 Revenue 15.5% · PAT 12.9% · OPM change 0.8 pp 83% evidence | 14.8/25 ROCE 3.8% · OPM 16.8% 76% evidence | 10.2/20 P/E 15.4× · PEG — 15% evidence | 15.3/20 RS sector 0.9% · RS bench 19.9% · 1Y 43.9%9 of 12 weeks ahead 100% evidence |
| Exact sum: 19.8 + 14.8 + 10.2 + 15.3 = 60.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4PACS Group, Inc.PACS | 58.7/100Thin evidence · provisional56% evidence | BREAKING OUT | 21.9/35 Revenue — · PAT — · OPM change 4.7 pp 39% evidence | 13.3/25 ROCE 5.2% · OPM 8.5% 76% evidence | 9.1/20 P/E 31.5× · PEG — 15% evidence | 14.4/20 RS sector 15% · RS bench 34% · 1Y 302.2%7 of 12 weeks ahead 100% evidence |
| Exact sum: 21.9 + 13.3 + 9.1 + 14.4 = 58.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Encompass Health CorporationEHC | 55.8/100Mixed-positive evidence81% evidence | BASING | 20.6/35 Revenue 10.1% · PAT 21% · OPM change 0.7 pp 83% evidence | 15.8/25 ROCE 4.9% · OPM 19% 76% evidence | 14.4/20 P/E 16.1× · PEG 0.68 65% evidence | 5.0/20 RS sector -25.7% · RS bench -10% · 1Y -6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.6 + 15.8 + 14.4 + 5 = 55.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Chemed CorporationCHE | 55.8/100Thin evidence · provisional58% evidence | BREAKING OUT | 18.0/35 Revenue — · PAT — · OPM change -1.7 pp 45% evidence | 15.7/25 ROCE 6.6% · OPM 12.9% 76% evidence | 9.5/20 P/E 23.4× · PEG — 15% evidence | 12.6/20 RS sector -8.7% · RS bench 9.9% · 1Y 24%7 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 15.7 + 9.5 + 12.6 = 55.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Fresenius Medical Care AGFMS | 55.0/100Mixed-positive evidence81% evidence | TURNING | 21.6/35 Revenue -0.7% · PAT 43.7% · OPM change 1.5 pp 83% evidence | 11.4/25 ROCE 2.1% · OPM 11.7% 76% evidence | 15.8/20 P/E 11.9× · PEG 0.22 65% evidence | 6.2/20 RS sector -25.4% · RS bench -9.8% · 1Y -0.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 11.4 + 15.8 + 6.2 = 55 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Addus HomeCare CorporationADUS | 54.4/100Mixed-positive evidence81% evidence | BREAKING OUT | 21.2/35 Revenue 19.5% · PAT 26.6% · OPM change 0.4 pp 83% evidence | 12.3/25 ROCE 2.7% · OPM 9.4% 76% evidence | 13.7/20 P/E 17.3× · PEG 0.78 65% evidence | 7.2/20 RS sector -21.4% · RS bench -4.9% · 1Y 3.1%5 of 12 weeks ahead 100% evidence |
| Exact sum: 21.2 + 12.3 + 13.7 + 7.2 = 54.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9LifeStance Health Group, Inc.LFST | 53.3/100Mixed-positive evidence64% evidence | BREAKING OUT | 22.1/35 Revenue 16.4% · PAT — · OPM change 5 pp 62% evidence | 5.8/25 ROCE 1.2% · OPM 5.5% 76% evidence | 8.5/20 P/E 106.2× · PEG — 15% evidence | 16.9/20 RS sector 10.2% · RS bench 29.9% · 1Y 134.8%9 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 5.8 + 8.5 + 16.9 = 53.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10agilon health, inc.AGL | 53.2/100Mixed-positive evidence61% evidence | LEADER | 18.4/35 Revenue -2.8% · PAT — · OPM change 1.7 pp 62% evidence | 4.8/25 ROCE 1% · OPM 0.3% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 20.0/20 RS sector 87% · RS bench 109.7% · 1Y 334%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 4.8 + 10 + 20 = 53.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Healthcare Services Group, Inc.HCSG | 53.2/100Thin evidence · provisional52% evidence | FADING | 22.9/35 Revenue — · PAT — · OPM change 2.2 pp 45% evidence | 10.6/25 ROCE 3.6% · OPM 7.3% 76% evidence | 10.4/20 P/E 14.3× · PEG — 15% evidence | 9.3/20 RS sector -10.3% · RS bench 6.7% · 1Y 60.9%6 of 12 weeks ahead 70% evidence |
| Exact sum: 22.9 + 10.6 + 10.4 + 9.3 = 53.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12DaVita Inc.DVA | 53.0/100Mixed-positive evidence81% evidence | LEADER | 16.1/35 Revenue 6.7% · PAT -6.9% · OPM change 0.5 pp 83% evidence | 13.7/25 ROCE 3.3% · OPM 14.1% 76% evidence | 8.0/20 P/E 14.3× · PEG 2.08 65% evidence | 15.2/20 RS sector 13.4% · RS bench 33.4% · 1Y 76.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 16.1 + 13.7 + 8 + 15.2 = 53 · Decision use: Price leads the evidence: RS versus the benchmark is 33.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 13Acadia Healthcare Company, Inc.ACHC | 49.1/100Thin evidence · provisional58% evidence | BREAKING OUT | 14.7/35 Revenue — · PAT — · OPM change 0.1 pp 45% evidence | 7.5/25 ROCE 1.1% · OPM 5.8% 76% evidence | 9.6/20 P/E 21.2× · PEG — 15% evidence | 17.3/20 RS sector 7.7% · RS bench 27.7% · 1Y 64.6%6 of 12 weeks ahead 100% evidence |
| Exact sum: 14.7 + 7.5 + 9.6 + 17.3 = 49.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14National HealthCare CorporationNHC | 47.5/100Mixed-negative evidence81% evidence | LEADER | 16.5/35 Revenue 10.3% · PAT 16.7% · OPM change 0.2 pp 83% evidence | 10.2/25 ROCE 2.5% · OPM 8.4% 76% evidence | 9.9/20 P/E 20.3× · PEG 1.48 65% evidence | 10.9/20 RS sector 1.4% · RS bench 19.5% · 1Y 107.4%10 of 12 weeks ahead 100% evidence |
| Exact sum: 16.5 + 10.2 + 9.9 + 10.9 = 47.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Guardian Pharmacy Services, Inc.GRDN | 46.8/100Mixed-negative evidence64% evidence | TURNING | 17.2/35 Revenue 13.6% · PAT — · OPM change 1.4 pp 62% evidence | 12.6/25 ROCE 7.8% · OPM 5.3% 76% evidence | 8.7/20 P/E 45.4× · PEG — 15% evidence | 8.3/20 RS sector -6.7% · RS bench 10.7% · 1Y 103%6 of 12 weeks ahead 100% evidence |
| Exact sum: 17.2 + 12.6 + 8.7 + 8.3 = 46.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16HCA Healthcare, Inc.HCA | 44.8/100Thin evidence · provisional58% evidence | BASING | 16.2/35 Revenue — · PAT — · OPM change -0.6 pp 45% evidence | 16.4/25 ROCE 6.9% · OPM 15% 76% evidence | 10.7/20 P/E 13.1× · PEG — 15% evidence | 1.5/20 RS sector -33.7% · RS bench -19.8% · 1Y 5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.2 + 16.4 + 10.7 + 1.5 = 44.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17The Pennant Group, Inc.PNTG | 44.7/100Mixed-negative evidence75% evidence | FADING | 20.4/35 Revenue 36.6% · PAT 20.7% · OPM change 0.1 pp 83% evidence | 9.2/25 ROCE 2.3% · OPM 6.1% 76% evidence | 4.0/20 P/E 35.9× · PEG 3.03 65% evidence | 11.1/20 RS sector -3.7% · RS bench 14.3% · 1Y 48.5%6 of 12 weeks ahead 70% evidence |
| Exact sum: 20.4 + 9.2 + 4 + 11.1 = 44.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Aveanna Healthcare Holdings Inc.AVAH | 44.5/100Thin evidence · provisional58% evidence | BREAKING OUT | 11.5/35 Revenue — · PAT — · OPM change -2.9 pp 45% evidence | 11.8/25 ROCE 4.8% · OPM 10.7% 76% evidence | 11.4/20 P/E 5.4× · PEG — 15% evidence | 9.8/20 RS sector -14.2% · RS bench 3.6% · 1Y 52.4%7 of 12 weeks ahead 100% evidence |
| Exact sum: 11.5 + 11.8 + 11.4 + 9.8 = 44.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Universal Health Services, Inc.UHS | 44.3/100Thin evidence · provisional58% evidence | BASING | 16.4/35 Revenue — · PAT — · OPM change 0.1 pp 45% evidence | 14.1/25 ROCE 4.1% · OPM 11.2% 76% evidence | 11.3/20 P/E 6.1× · PEG — 15% evidence | 2.5/20 RS sector -35.5% · RS bench -21.5% · 1Y -2.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.4 + 14.1 + 11.3 + 2.5 = 44.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Option Care Health, Inc.OPCH | 43.4/100Thin evidence · provisional58% evidence | TURNING | 17.0/35 Revenue — · PAT — · OPM change -0.5 pp 45% evidence | 11.3/25 ROCE 3.3% · OPM 5.4% 76% evidence | 10.1/20 P/E 15.8× · PEG — 15% evidence | 5.0/20 RS sector -37.2% · RS bench -23.5% · 1Y -16%2 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 11.3 + 10.1 + 5 = 43.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Pediatrix Medical Group, Inc.MD | 43.3/100Mixed-negative evidence74% evidence | FADING | 17.5/35 Revenue -2.2% · PAT — · OPM change 1.7 pp 62% evidence | 10.2/25 ROCE 2.5% · OPM 8.7% 76% evidence | 9.9/20 P/E 10.4× · PEG 1.7 65% evidence | 5.7/20 RS sector -11.9% · RS bench 5.1% · 1Y 72.4%7 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 10.2 + 9.9 + 5.7 = 43.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22The Ensign Group, Inc.ENSG | 42.2/100Thin evidence · provisional58% evidence | BASING | 17.7/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence | 12.2/25 ROCE 2.7% · OPM 9% 76% evidence | 9.3/20 P/E 25.1× · PEG — 15% evidence | 3.0/20 RS sector -27.5% · RS bench -12.6% · 1Y 9.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 12.2 + 9.3 + 3 = 42.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23Select Medical Holdings CorporationSEM | 40.7/100Mixed-negative evidence75% evidence | 11.1/35 Revenue 5.8% · PAT -20% · OPM change -1.4 pp 83% evidence | 9.7/25 ROCE 2% · OPM 6.9% 76% evidence | 13.1/20 P/E 15.4× · PEG 0.93 65% evidence | 6.8/20 RS sector -22.8% · RS bench 1.5% · 1Y 9%0 of 7 weeks ahead to 2026-07-02 70% evidence | |
| Exact sum: 11.1 + 9.7 + 13.1 + 6.8 = 40.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 24InnovAge Holding Corp.INNV | 39.7/100Thin evidence · provisional58% evidence | BREAKING OUT | 10.8/35 Revenue 14.2% · PAT — · OPM change -6.8 pp 62% evidence | 3.6/25 ROCE -8.8% · OPM -11.5% 76% evidence | 8.6/20 P/E 103.8× · PEG — 15% evidence | 16.7/20 RS sector 20% · RS bench 39.9% · 1Y 227.8%7 of 12 weeks ahead 70% evidence |
| Exact sum: 10.8 + 3.6 + 8.6 + 16.7 = 39.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25Brookdale Senior Living Inc.BKD | 39.3/100Mixed-negative evidence61% evidence | TURNING | 17.0/35 Revenue -0.4% · PAT — · OPM change 3.2 pp 62% evidence | 5.0/25 ROCE 0.9% · OPM 6.8% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 7.3/20 RS sector -10.3% · RS bench 6.1% · 1Y 97.4%2 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 5 + 10 + 7.3 = 39.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Ardent Health, Inc.ARDT | 39.2/100Mixed-negative evidence65% evidence | TURNING | 14.3/35 Revenue 6.7% · PAT -26.8% · OPM change 0.6 pp 83% evidence | 8.7/25 ROCE 1.9% · OPM 5.1% 76% evidence | 11.0/20 P/E 9× · PEG — 15% evidence | 5.2/20 RS sector -24.1% · RS bench -7.7% · 1Y -9.6%2 of 12 weeks ahead 70% evidence |
| Exact sum: 14.3 + 8.7 + 11 + 5.2 = 39.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Astrana Health, Inc.ASTH | 37.9/100Mixed-negative evidence81% evidence | FADING | 14.2/35 Revenue 56.8% · PAT -20.5% · OPM change -0.3 pp 83% evidence | 7.3/25 ROCE 2.2% · OPM 3% 76% evidence | 10.5/20 P/E 40.2× · PEG 1.17 65% evidence | 5.9/20 RS sector -10.4% · RS bench 6.4% · 1Y 27%10 of 12 weeks ahead 100% evidence |
| Exact sum: 14.2 + 7.3 + 10.5 + 5.9 = 37.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28Surgery Partners, Inc.SGRY | 36.7/100Mixed-negative evidence61% evidence | FADING | 13.9/35 Revenue 5.4% · PAT — · OPM change 0.1 pp 62% evidence | 7.2/25 ROCE 0.9% · OPM 8.1% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.6/20 RS sector -31% · RS bench -15.8% · 1Y -33.8%7 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 7.2 + 10 + 5.6 = 36.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Sonida Senior Living, Inc.SNDA | 34.2/100Adverse evidence64% evidence | FADING | 13.0/35 Revenue 25.5% · PAT — · OPM change -20.5 pp 62% evidence | 3.8/25 ROCE -1.9% · OPM -23.6% 76% evidence | 11.5/20 P/E 1.9× · PEG — 15% evidence | 5.9/20 RS sector -11.4% · RS bench 5.4% · 1Y 58.1%5 of 12 weeks ahead 100% evidence |
| Exact sum: 13 + 3.8 + 11.5 + 5.9 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 30COMPASS Pathways plcCMPS | 48.3/100Thin evidence · provisional47% evidence | LEADER | 19.8/35 Revenue — · PAT — · OPM change — 33% evidence | 5.0/25 ROCE -12.9% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 13.5/20 RS sector 18.2% · RS bench 37.9% · 1Y 168.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 19.8 + 5 + 10 + 13.5 = 48.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Showing 10 of 30 companies
04 · what price has already done
Market action
agilon health, inc. has the strongest one-year price move in Medical Care Facilities at +334%. It also leads on Mansfield relative strength against the S&P 500 at +109.7%. 21 of 30 covered companies are above zero on that measure. Every line covers 314 weekly closes through 2026-08-04.
Price and relative strength
Every company, the sector's own index and S&P 500 all start level on the left edge of the window, so only the distance between the lines counts — the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.
How far ahead of or behind S&P 500 each company has been running, measured against its own recent average of that comparison, so the flat line at zero IS S&P 500: above it the company is beating the market, below it the market is beating the company. It opens on one year.
The same measure taken against Medical Care Facilities itself instead of the whole market, so the flat line at zero is the sector: above it the company is beating its own peers, which is the sharper test of the two. It opens on one year.
05 · compare level, then change
Revenue Scale & Growth Durability
Fresenius Medical Care AG has the highest Revenue among the 30 Medical Care Facilities companies compared here, at $19,359 million. DaVita Inc. is next at $13,836 million. Astrana Health, Inc. has the highest Revenue growth at 56.8%, so level and change sit with different companies. 19 of 30 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Fresenius Medical Care AG is the scale leader at $19,359 million, 39.9% ahead of DaVita Inc.. Astrana Health, Inc.'s growth is 56.8% from a $3,527 million base, with 19 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.
LeaderFresenius Medical Care AG · $19,359 million
Gap39.9% versus #2 · DaVita Inc.
Persistence4/8 recent comparable periods
Coverage19/30 companies · 529 observations
Investor read: Fresenius Medical Care AG is the scale benchmark; Astrana Health, Inc. is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.
This conclusion weakens if: Fresenius Medical Care AG's growth falls below Astrana Health, Inc.'s for two consecutive comparable reports while operating margin also compresses.
Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.
Revenuelargest
Revenue growthfastest growers
Revenue · company comparison
19/30 level · 19/30 change
On every company-comparison chart on this page: solid lines show level, dotted lines show change when “Both” is selected, and a missing report breaks the line rather than being invented.
All-company data · latest reported quarter
In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
Full 20-quarter history · every available company
Revenue · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Concentra Group Holdings Parent, Inc. · CON
—
—
—
—
—
—
$456M
$467M
$474M
$441M
$468M
$478M
$490M
$465M
$501M
$551M
$573M
$539M
$570M
—
DaVita Inc. · DVA
$2.9B
$2.9B
$2.8B
$2.9B
$2.9B
$2.9B
$2.9B
$3.0B
$3.1B
$3.1B
$3.1B
$3.2B
$3.3B
$3.3B
$3.2B
$3.4B
$3.4B
$3.6B
$3.4B
—
Encompass Health Corporation · EHC
$1.0B
$1.0B
$1.1B
$1.1B
$1.1B
$1.1B
$1.2B
$1.2B
$1.2B
$1.2B
$1.3B
$1.3B
$1.4B
$1.4B
$1.5B
$1.5B
$1.5B
$1.5B
$1.6B
—
Fresenius Medical Care AG · FMS
$4.4B
$4.6B
$4.5B
$4.8B
$5.1B
$5.0B
$4.7B
$4.8B
$4.9B
$5.0B
$4.7B
$4.8B
$4.8B
$5.1B
$4.9B
$4.8B
$4.9B
$5.1B
$4.6B
—
HCA Healthcare, Inc. · HCA
$15.3B
$15.1B
$14.9B
$14.8B
$15.0B
$15.5B
$15.6B
$15.9B
$16.2B
$17.3B
$17.3B
$17.5B
$17.5B
$18.3B
$18.3B
$18.6B
$19.2B
$19.5B
$19.1B
—
LifeStance Health Group, Inc. · LFST
$174M
$190M
$203M
$210M
$218M
$229M
$253M
$260M
$263M
$281M
$300M
$312M
$313M
$325M
$333M
$345M
$364M
$382M
$403M
—
Option Care Health, Inc. · OPCH
$892M
$927M
$916M
$981M
$1.0B
$1.0B
$1.0B
$1.1B
$1.1B
$1.1B
$1.1B
$1.2B
$1.3B
$1.3B
$1.3B
$1.4B
$1.4B
$1.5B
$1.4B
—
PACS Group, Inc. · PACS
—
—
—
—
—
—
$708M
$761M
$789M
$853M
$920M
$982M
$1.0B
$1.2B
$1.3B
—
$1.3B
$1.4B
$1.4B
—
Tenet Healthcare Corporation · THC
$4.9B
$5.0B
$4.8B
$4.7B
$4.9B
$5.0B
$5.0B
$5.1B
$5.1B
$5.4B
$5.4B
$5.1B
$5.1B
$5.1B
$5.2B
$5.3B
$5.3B
$5.5B
$5.4B
—
The Ensign Group, Inc. · ENSG
$669M
$693M
$713M
$732M
$770M
$810M
$887M
$921M
$941M
$980M
$1.0B
$1.0B
$1.1B
$1.1B
$1.2B
$1.2B
$1.3B
$1.4B
$1.4B
—
Universal Health Services, Inc. · UHS
$3.2B
$3.3B
$3.3B
$3.3B
$3.3B
$3.4B
$3.5B
$3.5B
$3.6B
$3.7B
$3.8B
$3.9B
$4.0B
$4.1B
$4.1B
$4.3B
$4.5B
$4.5B
$4.5B
—
Revenue growth · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Chemed Corporation · CHE
—
—
—
-0.2%
-2.4%
1.1%
5.5%
4.3%
7.4%
7.1%
5.2%
7.6%
7.3%
9.2%
9.9%
3.9%
3.1%
-0.2%
1.7%
—
Concentra Group Holdings Parent, Inc. · CON
—
—
—
—
—
—
—
—
—
—
2.6%
2.4%
3.4%
5.4%
7.1%
15%
17%
16%
14%
—
DaVita Inc. · DVA
—
—
—
0.3%
0.4%
-0.9%
2.0%
2.5%
5.8%
7.9%
6.9%
6.2%
4.6%
4.7%
5.0%
6.1%
4.8%
9.9%
6.0%
—
Encompass Health Corporation · EHC
—
—
—
-17%
7.8%
9.0%
9.5%
12%
11%
9.7%
13%
9.6%
12%
13%
11%
12%
9.4%
10.0%
9.1%
—
Fresenius Medical Care AG · FMS
—
—
—
10%
15%
7.5%
3.4%
1.4%
-3.1%
-0.2%
0.5%
-1.2%
-3.6%
1.9%
3.3%
0.6%
2.6%
-0.3%
-5.5%
—
HCA Healthcare, Inc. · HCA
—
—
—
2.7%
-2.0%
2.9%
4.3%
7.0%
8.3%
12%
11%
10%
7.9%
5.7%
5.7%
6.4%
9.6%
6.7%
4.3%
—
LifeStance Health Group, Inc. · LFST
—
—
—
30%
25%
21%
25%
24%
21%
23%
19%
20%
19%
16%
11%
11%
16%
18%
21%
—
Option Care Health, Inc. · OPCH
—
—
—
14%
14%
11%
11%
9.0%
7.1%
9.4%
13%
15%
17%
20%
16%
15%
12%
8.8%
1.4%
—
PACS Group, Inc. · PACS
—
—
—
—
—
—
—
—
—
—
30%
29%
30%
42%
39%
—
31%
12%
11%
—
Tenet Healthcare Corporation · THC
—
—
—
-4.9%
-0.9%
0.7%
5.8%
7.6%
4.4%
7.3%
6.9%
0.4%
1.1%
-6.0%
-2.7%
3.2%
3.2%
9.0%
2.8%
—
The Ensign Group, Inc. · ENSG
—
—
—
15%
15%
17%
24%
26%
22%
21%
14%
12%
15%
16%
16%
19%
20%
20%
18%
—
Universal Health Services, Inc. · UHS
—
—
—
3.9%
5.7%
5.3%
5.3%
6.8%
6.8%
7.5%
11%
10%
11%
11%
6.7%
9.6%
13%
9.0%
9.6%
—
06 · compare level, then change
Operating Economics & Margin Trend
Tenet Healthcare Corporation has the highest OPM among the 30 Medical Care Facilities companies compared here, at 23.2%. Encompass Health Corporation is next at 19%. AMN Healthcare Services, Inc. has the highest Margin change at +6.7 percentage points, so level and change sit with different companies. 29 of 30 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Tenet Healthcare Corporation leads opm at 23.2%; AMN Healthcare Services, Inc. leads margin change at +6.7 percentage points.
LeaderTenet Healthcare Corporation · 23.2%
Gap22.1% versus #2 · Encompass Health Corporation
Persistence5/8 recent comparable periods
Coverage29/30 companies · 529 observations
Investor read: Tenet Healthcare Corporation sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current margin change signal.
Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.
OPMhighest
Margin changefastest expanders
Operating margin · company comparison
29/30 level · 29/30 change
All-company data · latest reported quarter
Full 20-quarter history · every available company
OPM · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Chemed Corporation · CHE
17%
18%
17%
17%
15%
15%
13%
13%
15%
19%
12%
15%
15%
18%
15%
11%
12%
16%
13%
—
Concentra Group Holdings Parent, Inc. · CON
—
—
—
—
—
—
17%
18%
17%
11%
16%
18%
18%
13%
16%
16%
17%
13%
17%
—
DaVita Inc. · DVA
16%
13%
12%
15%
11%
8.8%
11%
14%
16%
12%
16%
16%
16%
17%
14%
16%
15%
16%
14%
—
Encompass Health Corporation · EHC
17%
15%
14%
14%
14%
16%
15%
16%
15%
15%
16%
17%
16%
17%
18%
18%
17%
18%
19%
—
Fresenius Medical Care AG · FMS
11%
9.7%
7.6%
7.2%
9.3%
7.0%
5.5%
7.4%
6.6%
8.6%
5.2%
8.9%
9.7%
5.1%
10%
8.9%
9.8%
12%
12%
—
HCA Healthcare, Inc. · HCA
16%
16%
15%
16%
14%
16%
16%
15%
13%
16%
15%
16%
14%
16%
16%
16%
16%
16%
15%
—
LifeStance Health Group, Inc. · LFST
-72%
-60%
-32%
-29%
-18%
-20%
-14%
-19%
-28%
-12%
-5.6%
-5.1%
0.0%
0.3%
0.5%
-0.9%
2.0%
4.7%
5.5%
—
Option Care Health, Inc. · OPCH
5.9%
6.6%
5.7%
6.0%
5.9%
6.6%
6.6%
7.7%
7.4%
7.5%
6.0%
6.6%
6.7%
6.5%
5.9%
5.8%
5.9%
6.2%
5.4%
—
PACS Group, Inc. · PACS
—
—
—
—
—
—
8.4%
6.5%
4.6%
7.3%
7.1%
0.1%
2.2%
6.0%
3.8%
—
6.4%
7.0%
8.5%
—
Tenet Healthcare Corporation · THC
20%
14%
13%
11%
11%
9.4%
11%
11%
10%
12%
60%
14%
20%
15%
17%
15%
16%
14%
23%
—
The Ensign Group, Inc. · ENSG
9.9%
9.5%
9.7%
11%
9.6%
9.3%
8.4%
8.5%
8.5%
15%
8.1%
8.3%
8.3%
16%
8.6%
8.5%
7.4%
16%
9.0%
—
Universal Health Services, Inc. · UHS
10%
9.6%
7.1%
7.0%
8.3%
7.6%
8.0%
7.9%
8.0%
8.9%
10%
11%
9.7%
12%
11%
12%
12%
12%
11%
—
Margin change · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Chemed Corporation · CHE
—
—
—
+3.8 pp
−1.8 pp
−3.2 pp
−3.8 pp
−4.7 pp
0.0 pp
+4.1 pp
−0.7 pp
+2.2 pp
−0.2 pp
−1.2 pp
+2.3 pp
−3.8 pp
−3.2 pp
−2.1 pp
−1.7 pp
—
Concentra Group Holdings Parent, Inc. · CON
—
—
—
—
—
—
—
—
—
—
−0.4 pp
0.0 pp
+0.5 pp
+1.5 pp
−0.1 pp
−1.3 pp
−1.1 pp
+0.2 pp
+0.8 pp
—
DaVita Inc. · DVA
—
—
—
−2.0 pp
−5.6 pp
−4.4 pp
−1.2 pp
−1.3 pp
+5.3 pp
+3.6 pp
+5.0 pp
+2.4 pp
+0.5 pp
+4.8 pp
−2.2 pp
0.0 pp
−1.6 pp
−1.7 pp
+0.5 pp
—
Encompass Health Corporation · EHC
—
—
—
−2.9 pp
−2.9 pp
+1.3 pp
+1.0 pp
+1.4 pp
+1.3 pp
−0.6 pp
+0.4 pp
+1.1 pp
+0.6 pp
+1.3 pp
+2.5 pp
+1.2 pp
+1.0 pp
+1.8 pp
+0.7 pp
—
Fresenius Medical Care AG · FMS
—
—
—
−2.6 pp
−2.1 pp
−2.7 pp
−2.1 pp
+0.2 pp
−2.7 pp
+1.6 pp
−0.3 pp
+1.5 pp
+3.1 pp
−3.5 pp
+5.0 pp
0.0 pp
+0.1 pp
+6.6 pp
+1.5 pp
—
HCA Healthcare, Inc. · HCA
—
—
—
−1.7 pp
−1.9 pp
−0.2 pp
+0.9 pp
−1.0 pp
−1.4 pp
+0.6 pp
−0.8 pp
+1.1 pp
+0.9 pp
−0.6 pp
+0.8 pp
+0.3 pp
+1.7 pp
+0.7 pp
−0.6 pp
—
LifeStance Health Group, Inc. · LFST
—
—
—
+0.4 pp
+53.8 pp
+39.8 pp
+18.4 pp
+10.2 pp
−10.4 pp
+8.6 pp
+7.9 pp
+13.6 pp
+28.3 pp
+11.8 pp
+6.1 pp
+4.2 pp
+2.0 pp
+4.4 pp
+5.0 pp
—
Option Care Health, Inc. · OPCH
—
—
—
+0.4 pp
0.0 pp
0.0 pp
+0.9 pp
+1.7 pp
+1.5 pp
+0.9 pp
−0.6 pp
−1.1 pp
−0.7 pp
−1.0 pp
−0.1 pp
−0.8 pp
−0.8 pp
−0.3 pp
−0.5 pp
—
PACS Group, Inc. · PACS
—
—
—
—
—
—
—
—
—
—
−1.3 pp
−6.4 pp
−2.4 pp
−1.3 pp
−3.3 pp
—
+4.2 pp
+1.0 pp
+4.7 pp
—
Tenet Healthcare Corporation · THC
—
—
—
−0.2 pp
−8.6 pp
−4.1 pp
−1.7 pp
+0.3 pp
−1.0 pp
+2.9 pp
+49.1 pp
+2.9 pp
+9.8 pp
+2.3 pp
−43.1 pp
+0.8 pp
−4.4 pp
−0.7 pp
+6.2 pp
—
The Ensign Group, Inc. · ENSG
—
—
—
+0.5 pp
−0.3 pp
−0.2 pp
−1.3 pp
−2.2 pp
−1.1 pp
+5.9 pp
−0.3 pp
−0.2 pp
−0.2 pp
+0.6 pp
+0.5 pp
+0.2 pp
−0.9 pp
+0.5 pp
+0.4 pp
—
Universal Health Services, Inc. · UHS
—
—
—
−6.7 pp
−1.7 pp
−2.0 pp
+0.9 pp
+0.9 pp
−0.3 pp
+1.3 pp
+2.1 pp
+3.3 pp
+1.7 pp
+2.6 pp
+1.0 pp
+0.5 pp
+1.9 pp
0.0 pp
+0.1 pp
—
07 · compare level, then change
Profit Scale & Acceleration
Fresenius Medical Care AG has the highest Net profit among the 30 Medical Care Facilities companies compared here, at $1,167 million. DaVita Inc. is next at $1,096 million. The same company also holds the highest Profit growth, at 43.7%. 20 of 30 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Fresenius Medical Care AG leads with $1,167 million of TTM profit, 6.5% above DaVita Inc.. Fresenius Medical Care AG shows 43.7% growth from a $1,167 million profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.
LeaderFresenius Medical Care AG · $1,167 million
Gap6.5% versus #2 · DaVita Inc.
Persistence6/8 recent comparable periods
Coverage20/30 companies · 548 observations
Investor read: Fresenius Medical Care AG sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.
Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.
Net profitlargest
Profit growthfastest growers
Net profit · company comparison
20/30 level · 10/30 change
All-company data · latest reported quarter
Full 20-quarter history · every available company
Net profit · reported quarter history
Showing the 12 largest of 30 companies with a series here. The remaining 18 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Chemed Corporation · CHE
$72M
$75M
$64M
$66M
$57M
$62M
$54M
$53M
$75M
$90M
$65M
$71M
$76M
$90M
$72M
$52M
$64M
$77M
$66M
—
Concentra Group Holdings Parent, Inc. · CON
—
—
—
—
—
—
$47M
$54M
$54M
$29M
$50M
$53M
$46M
$23M
$41M
$46M
$50M
$36M
$52M
—
DaVita Inc. · DVA
$320M
$249M
$206M
$285M
$165M
$113M
$171M
$246M
$309M
$231M
$306M
$300M
$296M
$349M
$232M
$275M
$240M
$306M
$275M
—
Encompass Health Corporation · EHC
$102M
$92M
$86M
$60M
$86M
$119M
$114M
$118M
$115M
$128M
$140M
$148M
$148M
$164M
$197M
$186M
$175M
$202M
$232M
—
Fresenius Medical Care AG · FMS
$331M
$303M
$212M
$206M
$283M
$194M
$134M
$195M
$147M
$257M
$118M
$240M
$264M
$118M
$190M
$272M
$327M
$403M
$165M
—
HCA Healthcare, Inc. · HCA
$2.5B
$2.0B
$1.5B
$1.4B
$2.7B
$2.6B
$1.5B
$1.4B
$1.3B
$1.9B
$1.8B
$1.7B
$1.5B
$1.7B
$1.8B
$1.9B
$1.9B
$2.2B
$1.9B
—
LifeStance Health Group, Inc. · LFST
$-120M
$-108M
$-62M
$-69M
$-38M
$-47M
$-34M
$-45M
$-62M
$-45M
$-21M
$-23M
$-6M
$-7M
$1M
$-4M
$1M
$12M
$14M
—
Option Care Health, Inc. · OPCH
$35M
$75M
$30M
$34M
$39M
$48M
$39M
$114M
$56M
$57M
$45M
$53M
$54M
$60M
$47M
$51M
$52M
$59M
$45M
—
PACS Group, Inc. · PACS
—
—
—
—
—
—
$38M
$21M
$20M
$34M
$35M
$-11M
$16M
$36M
$28M
—
$52M
$60M
$81M
—
Tenet Healthcare Corporation · THC
$577M
$420M
$279M
$179M
$268M
$275M
$296M
$293M
$266M
$456M
$2.3B
$477M
$681M
$572M
$622M
$522M
$579M
$644M
$906M
—
The Ensign Group, Inc. · ENSG
$48M
$49M
$50M
$58M
$56M
$61M
$60M
$64M
$64M
$159M
$69M
$71M
$79M
$186M
$80M
$84M
$84M
$231M
$100M
—
Universal Health Services, Inc. · UHS
$219M
$234M
$151M
$159M
$177M
$170M
$162M
$169M
$168M
$220M
$266M
$294M
$266M
$337M
$322M
$363M
$379M
$448M
$359M
—
Profit growth · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Chemed Corporation · CHE
—
—
—
16%
-21%
-17%
-16%
-20%
32%
45%
20%
34%
1.3%
0.0%
11%
-27%
-16%
-14%
-8.3%
—
Concentra Group Holdings Parent, Inc. · CON
—
—
—
—
—
—
—
—
—
—
6.4%
-1.9%
-15%
-21%
-18%
-13%
8.7%
57%
27%
—
DaVita Inc. · DVA
—
—
—
-19%
-48%
-55%
-17%
-14%
87%
104%
79%
22%
-4.2%
51%
-24%
-8.3%
-19%
-12%
19%
—
Encompass Health Corporation · EHC
—
—
—
-58%
-16%
29%
33%
97%
34%
7.6%
23%
25%
29%
28%
41%
26%
18%
23%
18%
—
Fresenius Medical Care AG · FMS
—
—
—
-26%
-15%
-36%
-37%
-5.3%
-48%
32%
-12%
23%
80%
-54%
61%
13%
24%
242%
-13%
—
HCA Healthcare, Inc. · HCA
—
—
—
-17%
8.7%
32%
5.3%
2.4%
-53%
-30%
17%
19%
16%
-9.4%
1.3%
12%
28%
28%
1.8%
—
LifeStance Health Group, Inc. · LFST
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
1,300%
—
Option Care Health, Inc. · OPCH
—
—
—
6.3%
11%
-36%
30%
235%
44%
19%
15%
-54%
-3.6%
5.3%
4.4%
-3.8%
-3.7%
-1.7%
-4.3%
—
PACS Group, Inc. · PACS
—
—
—
—
—
—
—
—
—
—
-7.9%
-152%
-20%
5.9%
-20%
—
225%
67%
189%
—
Tenet Healthcare Corporation · THC
—
—
—
-31%
-54%
-35%
6.1%
64%
-0.8%
66%
689%
63%
156%
25%
-73%
9.4%
-15%
13%
46%
—
The Ensign Group, Inc. · ENSG
—
—
—
14%
17%
24%
20%
10%
14%
161%
15%
11%
23%
17%
16%
18%
6.3%
24%
25%
—
Universal Health Services, Inc. · UHS
—
—
—
-51%
-19%
-27%
7.3%
6.3%
-5.1%
29%
64%
74%
58%
53%
21%
23%
42%
33%
11%
—
08 · compare level, then change
Return On Capital Employed
Guardian Pharmacy Services, Inc. has the highest ROCE among the 30 Medical Care Facilities companies compared here, at 7.8%. AMN Healthcare Services, Inc. is next at 6.9%. Healthcare Services Group, Inc. has the highest ROCE change at +11.4 percentage points, so level and change sit with different companies. Its ROCE series carries 17 reported observations across the 20-quarter window.
What the numbers say: Guardian Pharmacy Services, Inc. leads ROCE at 7.8%, 0.9 percentage points above AMN Healthcare Services, Inc.. Healthcare Services Group, Inc. has the strongest latest improvement at +11.4 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.
LeaderGuardian Pharmacy Services, Inc. · 7.8%
Gap13% versus #2 · AMN Healthcare Services, Inc.
Persistence3/8 recent comparable periods
Coverage30/30 companies · 558 observations
Investor read: Guardian Pharmacy Services, Inc. sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current roce change signal.
ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.
ROCEhighest
ROCE changefastest improvers
4COMPASS Pathways plc CMPS+4.2 pp
Return on capital · company comparison
30/30 level · 30/30 change
All-company data · latest reported quarter
| Company | ROCE | ROCE change | Reported |
|---|---|---|---|
| Guardian Pharmacy Services, Inc. GRDN | 7.8% | −0.1 pp | Mar 2026 |
| HCA Healthcare, Inc. HCA | 6.9% | +0.1 pp | Jun 2026 |
| AMN Healthcare Services, Inc. AMN | 6.9% | +6.3 pp | Mar 2026 |
| Chemed Corporation CHE | 6.6% | +1.9 pp | Jun 2026 |
| Tenet Healthcare Corporation THC | 5.8% | +2.6 pp | Jun 2026 |
| PACS Group, Inc. PACS | 5.2% | +2.3 pp | Mar 2026 |
| Encompass Health Corporation EHC | 4.9% | +0.2 pp | Mar 2026 |
| Aveanna Healthcare Holdings Inc. AVAH | 4.8% | −1.3 pp | Jun 2026 |
| Universal Health Services, Inc. UHS | 4.1% | 0.0 pp | Jun 2026 |
| Concentra Group Holdings Parent, Inc. CON | 3.8% | +0.2 pp | Mar 2026 |
| Healthcare Services Group, Inc. HCSG | 3.6% | +11.4 pp | Jun 2026 |
| DaVita Inc. DVA | 3.3% | +0.3 pp | Mar 2026 |
| Option Care Health, Inc. OPCH | 3.3% | +0.2 pp | Jun 2026 |
| The Ensign Group, Inc. ENSG | 2.7% | +0.1 pp | Jun 2026 |
| Addus HomeCare Corporation ADUS | 2.7% | −0.2 pp | Mar 2026 |
| National HealthCare Corporation NHC | 2.5% | 0.0 pp | Mar 2026 |
| Pediatrix Medical Group, Inc. MD | 2.5% | +0.7 pp | Mar 2026 |
| The Pennant Group, Inc. PNTG | 2.3% | +0.1 pp | Mar 2026 |
| Astrana Health, Inc. ASTH | 2.2% | 0.0 pp | Mar 2026 |
| Fresenius Medical Care AG FMS | 2.1% | +0.3 pp | Mar 2026 |
| Select Medical Holdings Corporation SEM | 2.0% | 0.0 pp | Mar 2026 |
| Ardent Health, Inc. ARDT | 1.9% | +0.2 pp | Mar 2026 |
| LifeStance Health Group, Inc. LFST | 1.2% | +1.1 pp | Mar 2026 |
| Acadia Healthcare Company, Inc. ACHC | 1.1% | −0.3 pp | Jun 2026 |
| agilon health, inc. AGL | 1.0% | +4.3 pp | Mar 2026 |
| Brookdale Senior Living Inc. BKD | 0.9% | +0.3 pp | Mar 2026 |
| Surgery Partners, Inc. SGRY | 0.9% | 0.0 pp | Mar 2026 |
| Sonida Senior Living, Inc. SNDA | -1.9% | −1.5 pp | Mar 2026 |
| InnovAge Holding Corp. INNV | -8.8% | −6.0 pp | Mar 2026 |
| COMPASS Pathways plc CMPS | -13% | +4.2 pp | Mar 2026 |
Full 20-quarter history · every available company
ROCE · reported quarter history
Showing the 12 largest of 30 companies with a series here. The remaining 18 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Chemed Corporation · CHE
9.0%
9.0%
8.1%
8.6%
7.7%
7.4%
6.7%
6.2%
7.5%
8.9%
5.6%
6.6%
6.7%
8.3%
6.6%
4.7%
5.3%
7.6%
6.4%
6.6%
Concentra Group Holdings Parent, Inc. · CON
—
—
—
—
0.0%
0.0%
—
—
4.0%
2.4%
7.2%
8.0%
4.0%
2.8%
3.6%
3.9%
4.0%
2.9%
3.8%
—
DaVita Inc. · DVA
3.2%
2.7%
2.3%
2.9%
2.1%
1.8%
2.2%
2.8%
3.4%
2.7%
3.3%
3.5%
3.7%
4.0%
3.0%
3.8%
3.5%
3.9%
3.3%
—
Encompass Health Corporation · EHC
2.8%
2.6%
2.6%
2.5%
2.7%
3.2%
3.1%
3.2%
3.5%
3.6%
3.9%
4.0%
3.8%
4.2%
4.7%
4.5%
4.2%
4.7%
4.9%
—
Fresenius Medical Care AG · FMS
1.9%
1.7%
1.3%
1.2%
1.6%
1.2%
0.9%
1.2%
1.1%
1.5%
0.9%
1.5%
1.7%
0.9%
1.8%
1.6%
1.8%
2.3%
2.1%
—
HCA Healthcare, Inc. · HCA
6.5%
6.0%
5.5%
5.6%
5.3%
5.8%
5.8%
5.4%
5.0%
6.5%
6.0%
6.4%
5.6%
6.5%
6.3%
6.8%
6.9%
7.2%
6.5%
6.9%
LifeStance Health Group, Inc. · LFST
-7.5%
-6.9%
-3.9%
-3.3%
-2.1%
-2.4%
-1.8%
-2.5%
-3.9%
-1.7%
-0.9%
-0.8%
0.0%
0.1%
0.1%
-0.2%
0.4%
0.9%
1.2%
—
Option Care Health, Inc. · OPCH
2.3%
2.7%
2.3%
2.5%
2.5%
2.8%
2.7%
3.2%
3.2%
3.3%
2.7%
3.0%
3.2%
3.3%
3.0%
3.1%
3.2%
3.5%
2.8%
3.3%
PACS Group, Inc. · PACS
0.0%
0.0%
—
—
0.0%
0.0%
1.4%
—
1.4%
2.5%
1.7%
0.0%
0.7%
2.0%
2.9%
—
2.0%
2.1%
5.2%
—
Tenet Healthcare Corporation · THC
4.7%
3.0%
2.8%
2.3%
2.5%
2.1%
2.5%
2.4%
2.2%
2.9%
14%
3.0%
4.4%
3.1%
3.7%
3.2%
3.4%
3.1%
5.0%
5.8%
The Ensign Group, Inc. · ENSG
3.1%
3.0%
3.0%
3.3%
3.0%
2.9%
2.6%
2.6%
2.6%
4.7%
2.4%
2.4%
2.5%
4.9%
2.6%
2.6%
2.3%
5.2%
2.8%
2.7%
Universal Health Services, Inc. · UHS
3.0%
2.8%
2.1%
2.1%
2.5%
2.3%
2.5%
2.4%
2.4%
2.8%
3.3%
3.7%
3.2%
3.9%
3.7%
4.1%
4.3%
4.2%
4.0%
4.1%
ROCE change · reported quarter history
Showing the 12 largest of 30 companies with a series here. The remaining 18 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Chemed Corporation · CHE
—
—
—
—
−1.3 pp
−1.6 pp
−1.4 pp
−2.4 pp
−0.2 pp
+1.5 pp
−1.1 pp
+0.4 pp
−0.8 pp
−0.6 pp
+1.0 pp
−1.9 pp
−1.4 pp
−0.7 pp
−0.2 pp
+1.9 pp
Concentra Group Holdings Parent, Inc. · CON
—
—
—
—
—
—
—
—
+4.0 pp
+2.4 pp
—
—
0.0 pp
+0.4 pp
−3.6 pp
−4.1 pp
0.0 pp
+0.1 pp
+0.2 pp
—
DaVita Inc. · DVA
—
—
—
—
−1.1 pp
−0.9 pp
−0.1 pp
−0.1 pp
+1.3 pp
+0.9 pp
+1.1 pp
+0.7 pp
+0.3 pp
+1.3 pp
−0.3 pp
+0.3 pp
−0.2 pp
−0.1 pp
+0.3 pp
—
Encompass Health Corporation · EHC
—
—
—
—
−0.1 pp
+0.6 pp
+0.5 pp
+0.7 pp
+0.8 pp
+0.4 pp
+0.8 pp
+0.8 pp
+0.3 pp
+0.6 pp
+0.8 pp
+0.5 pp
+0.4 pp
+0.5 pp
+0.2 pp
—
Fresenius Medical Care AG · FMS
—
—
—
—
−0.3 pp
−0.5 pp
−0.4 pp
0.0 pp
−0.5 pp
+0.3 pp
0.0 pp
+0.3 pp
+0.6 pp
−0.6 pp
+0.9 pp
+0.1 pp
+0.1 pp
+1.4 pp
+0.3 pp
—
HCA Healthcare, Inc. · HCA
—
—
—
—
−1.2 pp
−0.2 pp
+0.3 pp
−0.2 pp
−0.3 pp
+0.7 pp
+0.2 pp
+1.0 pp
+0.6 pp
0.0 pp
+0.3 pp
+0.4 pp
+1.3 pp
+0.7 pp
+0.2 pp
+0.1 pp
LifeStance Health Group, Inc. · LFST
—
—
—
—
+5.4 pp
+4.5 pp
+2.1 pp
+0.8 pp
−1.8 pp
+0.7 pp
+0.9 pp
+1.7 pp
+3.9 pp
+1.8 pp
+1.0 pp
+0.6 pp
+0.4 pp
+0.8 pp
+1.1 pp
—
Option Care Health, Inc. · OPCH
—
—
—
—
+0.2 pp
+0.1 pp
+0.4 pp
+0.7 pp
+0.7 pp
+0.5 pp
0.0 pp
−0.2 pp
0.0 pp
0.0 pp
+0.3 pp
+0.1 pp
0.0 pp
+0.2 pp
−0.2 pp
+0.2 pp
PACS Group, Inc. · PACS
—
—
—
—
0.0 pp
0.0 pp
—
—
+1.4 pp
+2.5 pp
+0.3 pp
—
−0.7 pp
−0.5 pp
+1.2 pp
—
+1.3 pp
+0.1 pp
+2.3 pp
—
Tenet Healthcare Corporation · THC
—
—
—
—
−2.2 pp
−0.9 pp
−0.3 pp
+0.1 pp
−0.3 pp
+0.8 pp
+11.4 pp
+0.6 pp
+2.2 pp
+0.2 pp
−10.2 pp
+0.2 pp
−1.0 pp
0.0 pp
+1.3 pp
+2.6 pp
The Ensign Group, Inc. · ENSG
—
—
—
—
−0.1 pp
−0.1 pp
−0.4 pp
−0.7 pp
−0.4 pp
+1.8 pp
−0.2 pp
−0.2 pp
−0.1 pp
+0.2 pp
+0.2 pp
+0.2 pp
−0.2 pp
+0.3 pp
+0.2 pp
+0.1 pp
Universal Health Services, Inc. · UHS
—
—
—
—
−0.5 pp
−0.5 pp
+0.4 pp
+0.3 pp
−0.1 pp
+0.5 pp
+0.8 pp
+1.3 pp
+0.8 pp
+1.1 pp
+0.4 pp
+0.4 pp
+1.1 pp
+0.3 pp
+0.3 pp
0.0 pp
09 · compare level, then change
Valuation Against Growth & Quality
Fresenius Medical Care AG has the lowest PEG among the 30 Medical Care Facilities companies compared here, at 0.22×. Encompass Health Corporation is next at 0.68×. Sonida Senior Living, Inc. has the lowest P/E at 1.92×, so level and change sit with different companies. 9 of 30 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Fresenius Medical Care AG has the lowest comparable PEG at 0.22×, 67.6% below Encompass Health Corporation. Only 9 of 30 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.
LeaderFresenius Medical Care AG · 0.22×
Gap67.6% versus #2 · Encompass Health Corporation
Persistence0/8 recent comparable periods
Coverage9/30 companies · 104 observations
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/e signal.
PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is recomputed consistently as the trailing P/E divided by that growth rate — reported earnings, never an expected-earnings multiple. On Indian companies it is shown only where the two data feeds agreed. Where any of that fails the ratio is left out rather than printed: a P/E divided by a loss, or by growth measured off a tiny base, is a number that looks precise and means nothing.
PEGlowest PEG
P/Elowest P/E
Valuation · company comparison
9/30 level · 26/30 change
All-company data · latest reported quarter
Full 20-quarter history · every available company
PEG · reported quarter history
Showing the 12 largest of 17 companies with a series here. The remaining 5 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Acadia Healthcare Company, Inc. · ACHC
—
—
—
—
—
—
1.6
—
—
—
—
—
—
—
—
—
—
—
—
—
Addus HomeCare Corporation · ADUS
—
—
—
—
—
—
2.5
1.2
0.8
0.7
0.9
1.0
1.3
2.8
2.3
3.5
3.7
0.9
0.8
—
Chemed Corporation · CHE
—
—
—
—
—
—
—
—
—
3.9
2.0
0.9
1.4
2.4
2.9
—
—
—
—
—
DaVita Inc. · DVA
—
—
—
—
—
—
—
—
—
0.5
—
—
0.4
0.3
1.0
1.7
—
—
2.1
—
Encompass Health Corporation · EHC
—
—
—
—
—
—
—
0.6
0.4
0.5
0.7
1.2
1.3
0.7
0.7
0.8
0.9
0.8
0.7
—
Fresenius Medical Care AG · FMS
—
—
—
—
—
—
—
—
—
—
—
—
0.4
2.9
0.8
0.9
2.1
—
0.2
—
HCA Healthcare, Inc. · HCA
—
—
—
—
—
—
—
—
0.8
—
—
—
1.9
0.9
1.3
1.4
1.0
0.6
0.6
—
National HealthCare Corporation · NHC
—
—
—
—
—
—
—
—
0.5
—
—
—
—
0.3
0.4
1.2
—
1.0
1.5
—
Option Care Health, Inc. · OPCH
—
—
—
—
—
—
—
0.7
0.5
—
—
—
—
—
—
5.2
3.8
—
—
—
Tenet Healthcare Corporation · THC
—
—
—
—
—
—
—
—
—
0.2
—
—
—
—
—
—
—
—
0.4
—
The Ensign Group, Inc. · ENSG
—
—
—
—
—
—
1.2
1.3
1.4
—
—
—
—
0.7
0.6
0.7
0.9
2.1
2.0
—
Universal Health Services, Inc. · UHS
—
—
—
—
—
—
—
—
—
1.2
0.6
0.3
0.3
—
0.2
0.2
0.2
0.3
0.2
—
P/E · reported quarter history
Showing the 12 largest of 26 companies with a series here. The remaining 14 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Chemed Corporation · CHE
24.4
31.4
29.6
26.1
25.4
30.9
33.8
36.1
32.2
32.6
34.6
27.5
30.4
26.6
30.0
25.0
23.7
23.3
20.6
23.4
Concentra Group Holdings Parent, Inc. · CON
—
—
—
—
—
—
—
—
—
—
—
—
13.9
13.6
16.2
17.3
17.4
15.1
15.4
—
DaVita Inc. · DVA
13.3
12.8
13.5
9.9
12.1
12.8
15.4
20.6
14.8
14.1
15.7
14.8
17.7
13.9
15.2
14.0
13.7
11.6
14.3
—
Encompass Health Corporation · EHC
15.6
17.4
17.6
18.1
19.4
23.4
19.4
20.5
19.1
19.2
22.3
21.8
23.3
20.7
20.9
24.0
24.0
19.2
16.1
—
Fresenius Medical Care AG · FMS
19.2
17.3
20.3
17.3
11.0
13.3
19.2
21.7
26.6
22.2
21.7
19.7
17.0
23.8
21.7
21.6
18.2
12.1
11.9
—
HCA Healthcare, Inc. · HCA
12.4
12.1
11.8
8.1
10.4
12.5
13.2
14.9
12.1
14.3
16.6
15.1
18.3
13.6
15.4
16.1
16.5
16.5
16.3
13.1
LifeStance Health Group, Inc. · LFST
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
352.0
106.2
—
Option Care Health, Inc. · OPCH
52.7
36.9
29.8
28.7
32.1
36.3
36.5
24.8
22.9
22.8
22.1
23.3
26.3
18.9
28.2
26.0
22.0
25.1
20.9
15.8
PACS Group, Inc. · PACS
—
—
—
—
—
—
—
—
—
—
—
46.1
67.8
34.5
36.3
—
36.1
31.5
—
—
Tenet Healthcare Corporation · THC
6.7
9.7
9.8
6.5
10.2
12.9
15.9
17.9
15.2
13.2
4.1
4.9
5.3
3.9
8.9
11.3
13.9
12.8
9.8
7.2
The Ensign Group, Inc. · ENSG
22.2
24.6
26.1
20.5
21.2
24.0
23.3
22.6
21.4
30.7
32.7
31.7
34.8
26.0
24.5
28.0
30.9
29.8
32.8
25.1
Universal Health Services, Inc. · UHS
11.1
11.0
12.7
10.3
9.1
15.4
13.5
16.4
13.2
14.9
15.5
13.6
15.2
10.7
10.5
9.5
9.7
9.4
7.5
6.1
10 · before the conclusion, check the blind spots
What can make this comparison misleading?
This Medical Care Facilities comparison names 4 specific ways its own evidence can mislead, all listed below. All 30 companies here report on comparable dates, so no rank carries a stale marker. A high growth rate can still be a low-base artefact.
Keep these limits visible
- A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
- A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
- The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
- An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
11 · evidence and freshness
How was this comparison built?
This comparison is built from the reported filings of 30 Medical Care Facilities companies, normalized to a common $ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-08-04. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.
FundamentalsThrough Jun 2026 · up to 20 quarters per company
Market dataThrough 2026-08-04 · weekly price and relative-strength history
Derived metricsGrowth, changes and PEG are calculated only when their inputs are comparable.
Score confidenceMissing and stale evidence reduces confidence and pulls the 0–100 research-priority score toward neutral.
12 · questions investors ask, short speakable answers
Medical Care Facilities company comparison FAQs
These 22 answers restate the Medical Care Facilities comparison above in question form. Every one is computed from the same 30 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-08-04. Nothing here is estimated, and none of it is a recommendation.
Is the Medical Care Facilities sector outperforming S&P 500?
Medical Care Facilities has outperformed S&P 500 by 45.7% over 52 weeks and 11.6% over 13 weeks. 21 of 30 covered companies beat the S&P 500 on Mansfield relative strength, while 10 of 30 beat the sector itself.
Which Medical Care Facilities company is largest by revenue?
Fresenius Medical Care AG leads with revenue of $19,359 million, based on 19 of 30 comparable companies through Mar 2026.
Which Medical Care Facilities company is growing fastest?
Astrana Health, Inc. has the fastest current revenue growth at 56.8%, across 19 of 30 comparable companies.
Which Medical Care Facilities company has the strongest 4-Factor Sector Score?
AMN Healthcare Services, Inc. ranks first at 64.5/100 with 57.6% evidence confidence. The score prioritizes research; it is not a buy recommendation.
Which Medical Care Facilities company has the lowest comparable PEG?
Fresenius Medical Care AG has the lowest comparable PEG at 0.22, among 9 of 30 companies whose earnings and growth are steady enough for the ratio to mean anything.
How much history does this Medical Care Facilities comparison include?
The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.
How is the 4-Factor Sector Score calculated?
The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.
Which Medical Care Facilities company is the biggest?
Fresenius Medical Care AG is the largest, with trailing-twelve-month revenue of $19,359 million, ahead of DaVita Inc. at $13,836 million. That covers 19 of 30 companies with comparable reporting through Mar 2026.
Which Medical Care Facilities company has the best profit margins?
Tenet Healthcare Corporation has the highest operating margin at 23.2%, from 29 of 30 comparable companies. AMN Healthcare Services, Inc. shows the biggest recent improvement, at +6.7 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.
Which Medical Care Facilities company makes the most profit?
Fresenius Medical Care AG earns the most, at $1,167 million of trailing-twelve-month net profit, from 20 of 30 comparable companies. Fresenius Medical Care AG has the fastest profit growth at 43.7%, though growth off a small or recovering profit base overstates how much has actually changed.
Which Medical Care Facilities company earns the highest return on capital?
Guardian Pharmacy Services, Inc. leads on return on capital employed at 7.8%, across 30 of 30 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.
Which Medical Care Facilities stock is the cheapest?
On PEG — where a LOWER number is cheaper — Fresenius Medical Care AG screens cheapest at 0.22×. Only 9 of 30 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.
Is the Medical Care Facilities sector beating the market?
Medical Care Facilities has outperformed S&P 500 by 45.7% over the last 52 weeks and 11.6% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 21 of 30 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.
Which Medical Care Facilities stock has the strongest price momentum?
agilon health, inc. has the strongest relative strength against S&P 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.
Which Medical Care Facilities company scores highest for research priority?
AMN Healthcare Services, Inc. scores 64.5 out of 100 with 57.6% evidence confidence, from 26 points on growth and earnings, 13.2 on capital efficiency, 9.2 on valuation and 16.1 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.
How many Medical Care Facilities companies does this comparison cover, and over what period?
It compares 30 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.
What is the total market cap of the Medical Care Facilities sector?
The 30 Medical Care Facilities companies on this page carry $227,507 million of combined market value. HCA Healthcare, Inc. is the largest at $86,759 million, about 38% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-08-04.
What is the Medical Care Facilities sector's P/E ratio?
The median price-to-earnings ratio across the 30 Medical Care Facilities companies on this page is 16.1×, measured on the 26 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past. Figures are as of 2026-08-04.
How is the Medical Care Facilities sector performing?
21 of the 30 covered Medical Care Facilities companies are beating S&P 500 on Mansfield relative strength. The sector itself is 45.7% ahead of S&P 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-08-04.
How many Medical Care Facilities stocks are listed in the US?
This comparison covers 30 listed Medical Care Facilities companies in the US, each above the size floor the site applies. The full ranked list is on this page, with reported fundamentals through Jun 2026. Membership is the full industry list — nothing is dropped for having thin data.
Why are some values on this page blank?
A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.
Is this investment advice?
No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.